Free Trial
LON:BIOG

The Biotech Growth Trust Interim Earnings Report

The Biotech Growth Trust logo
GBX 1,262 +22.00 (+1.77%)
As of 06/11/2026 12:00 PM Eastern

The Biotech Growth Trust EPS Results

Actual EPS
-GBX 1
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

The Biotech Growth Trust Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

The Biotech Growth Trust Announcement Details

Quarter
Interim
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

The Biotech Growth Trust Earnings Headlines

The Biotech Growth Trust PLC - Annual Financial Report
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel
See More The Biotech Growth Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email.

About The Biotech Growth Trust

The Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

View The Biotech Growth Trust Profile